Xi`an Libang Group Investment Co.,Ltd

Established in 1996 by returnee after abroad studying, Xi`an Libang Group Investment Co.,Ltd mainly engagesin research, development, production and sales of generic and proprietary branded pharmaceuticals and activepharmaceutical ingredients. Over the last decade of development, Libang Group has controlled nine subsidiaries,Xi`an Libang Pharmaceutical Co., Ltd., Xi`an Libang Medical Distribution Co., Ltd., Xi`an Libang Pharmaceutical Sciences Co.,Ltd., Xi`an Libang Fine Chemical Co., Ltd., Xi`an Libang Clinical Nutrition Co.,Ltd., Shaanxi North Pharmaceutical Co., Ltd, Shaanxi Sunkind Pharmaceutical Co., Ltd, Baoji Libang Biological Engineering Co., Ltd.,and Canada Lipont Pharmaceutical Inc. As a medium-sized pharmaceutical group, Libang has 800 employees toproduce 20 APIs, 50 formulations with total assets of RMB400 million. In 2005, its sales revenue from medicines has eached RMB 300 million with the total amount of tax and profits of RMB 50 million. Libang has been entitled as Xi`an Star Hi-tech Enterprise, Outstanding Tax Contributions and Provincial Excellent Enterprise. while concentrating on the development of market, Libang will take the road of standardization, specialization, collectivization, internationalization. For operating mode, taking the subsidiary companies as managing entity centered on the products operation, based on the company management, taking assets trade and capital operation for resort, with technology R&D as accelerator, ensuring Libang Enterprises stronger, expanding, and a sustained development on Prescription Drug, OTC, Clinical Nutrition Product and APIs. Strength nation enterprise subordinate company: Xi`an Libang Pharmaceutical Co., Ltd., Xi`an Libang Medical Distribution Co., Ltd., Xi`an Libang Pharmaceutical Sciences Co.,Ltd., Xi`an Libang API Manufactural Base Xi`an Libang Clinical Nutrition Co.,Ltd., Shaanxi North Pharmaceutical Co., Ltd, Shaanxi Sunkind Pharmaceutical Co., Ltd, Baoji Libang Biological Engineering Co., Ltd., Canada Lipont Pharmaceutical Inc